Scotland’s National Health Service saw a dramatic increase in the prescription of semaglutide, known commercially as Ozempic and Wegovy, as the annual number of prescriptions rose to 168,486 in 2024
All posts tagged in NHS Scotland
1Article
- Home
- NHS Scotland
Recent Posts
- Nandos KFC and Other Chains Ditch Commitment to Slow Growing Chickens
- Paramount Wins Warner Bros but Challenges Arise for Filmmaking
- Electric Car Charging Stations Overcharge Drivers
- Trump Insiders Accused of Profiting from War After $1 Million Dollar Bet on Iran Attack
- Oil Prices Surge Amid Disruption of Middle Eastern Supply Chains
- Aria Launches Fifty Million Pound AI Chip Testbed Facility
- Wayve Attracts Major Investment Valued at $8.6 Billion Dollars
- Co-op Group Navigates Challenging Retail Landscape
- Denmark’s Pharmaceutical Giant Faces Economic Challenges
- John Lewis Plans To Buy Back Waitrose Supermarkets
- OpenAI Achieves Record Valuation After Major Funding Round
- Advent International Considering Bid for Senior Engineering Group
- Donald Trump Orders Ban on Anthropic Technology Amidst Controversy
- Jim Ratcliffe invests in Ineos Project One chemicals plant despite significant market challenges
- International Airlines Group reports strong financial results and plans significant share buyback
- Heathrow Airport Third Runway Estimated Cost Nears One Million Pounds Per Metre
- Barclays Faces Scrutiny After MultiMillion Pound Exposure to Loan Provider
- Collapse of Mortgage Lender Unveils Significant Financial Risks
- Rachel Reeves set to collect £40 billion in student loan interest
- Tyrrells Ends Non Potato Vegetable Crisps Range
- Rightmove shares rise as AI threat downplayed
- Paramount Wins Battle for Warner Bros Discovery
- FTSE 100 Marks Record Gains in February
- Trump tariffs push UK businesses closer to China
- Ed Miliband Opens Door to Increased Chinese Investment in UK Energy Sector
- UK Ministry of Defence Approves £1 Billion Helicopter Contract
- Anthropic Seeks to Position Claude as Core Enterprise Infrastructure Rather Than Standalone Tool
- Netflix Walks Away from Warner Bros Bid as Paramount Offers Superior Deal
- Cindy Rose Unveils Strategy to Overhaul WPP
- OpenAI Expands Research Presence in London Amid AI Talent Competition
